Randomized Controlled Trial of Single-Agent Paclitaxel Versus Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Recurrent Ovarian Cancer Who Responded to First-Line Platinum-Based Regimens
- 1 March 2002
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (5) , 1232-1237
- https://doi.org/10.1200/jco.2002.20.5.1232
Abstract
PURPOSE: To assess the activity, efficacy, and tolerability of single-agent paclitaxel and a platinum-containing regimen in previously treated patients with recurrent ovarian cancer. PATIENTS AND M...Keywords
This publication has 29 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Chemotherapy of ovarian cancerPublished by Springer Nature ,1998
- Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patientsAnnals of Oncology, 1997
- Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposideGynecologic Oncology, 1991
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979
- The granulated peripolar epithelial cell: a potential secretory component of the renal juxtaglomerular complexNature, 1979